• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC, INC. AORTIC AP; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC, INC. AORTIC AP; HEART-VALVE, MECHANICAL Back to Search Results
Model Number 505DA
Device Problems Inadequacy of Device Shape and/or Size (1583); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Laceration(s) (1946)
Event Date 07/14/2017
Event Type  Injury  
Manufacturer Narrative
Conclusion: product analysis is in progress.When analysis results are complete, a supplemental report will be submitted.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information during the implant of this 20 mm mechanical valve, when stitching the valve while tying the suture line knot, a laceration on the aortic wall occurred.The valve was explanted and an 18 mm mechanical valve was implanted with no further adverse patient effects reported.
 
Manufacturer Narrative
Upon receipt at medtronic¿s quality laboratory, the valve was slightly discolored showing evidence of blood contact.The serial number was verified to be correct.There were no surgeon¿s sutures returned with the valve and suture holes from the surgeon¿s suture placement could not be confirmed.Both leaflets were in the closed position and no evidence of damage such as cracks and/or surface anomalies were noted.Both inflow and outflow valve hinge mechanisms were intact with no evidence of damage.Using an actuator to test leaflet movement, the leaflets moved without difficulty.It was verified that the carbon subassembly rotated in the sewing ring.The device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.Based on the results of the analysis, the device is considered acceptable.Based on the reported information, the cause of the laceration on the aortic wall could potentially be due to technical error related to sizing or implant technique.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC AP
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
MEDTRONIC, INC.
3800 annapolis lane
minneapolis MN 55447
Manufacturer (Section G)
MEDTRONIC, INC.
3800 annapolis lane
minneapolis MN 55447
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key6773992
MDR Text Key82051918
Report Number3008592544-2017-00042
Device Sequence Number1
Product Code LWQ
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P990046
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/24/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/08/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/06/2021
Device Model Number505DA
Device Catalogue Number505DA20
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/04/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/24/2017
Was Device Evaluated by Manufacturer? No
Date Device Manufactured10/06/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age59 YR
-
-